Identification of drug targets by chemogenomic and metabolomic profiling in yeast

Pharmacogenetics and Genomics

Volumn 22, Issue 12, 2012, Pages 877-886

  Wu, Manhong ^a   Zheng, Ming ^a   Zhang, Weiruo ^b   Suresh, Sundari ^a   Schlecht, Ulrich ^a   Fitch, William L ^a   Aronova, Sofia ^c   Baumann, Stephan ^c   Davis, Ronald ^a   St onge, Robert ^a   Dill, David L ^b   Peltz, Gary ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY   (United States)

^c AGILENT TECHNOLOGIES   (United States)

Author keywords

chemogenomics; metabolomics; pharmacology

Indexed keywords

ANTIFUNGAL AGENT; ERGOSTEROL; FLUCONAZOLE; HARMINE; MEBHYDROLIN; NATURAL PRODUCT; TERBINAFINE; TOTAROL; UNCLASSIFIED DRUG;

ARTICLE; FUNGAL GENETICS; FUNGAL GENOME; FUNGAL STRAIN; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENOME ANALYSIS; METABOLOMICS; MOLECULARLY TARGETED THERAPY; NONHUMAN; PRIORITY JOURNAL; SACCHAROMYCES CEREVISIAE;

EID: 84870362521     PISSN: 17446872     EISSN: 17446880     Source Type: Journal    
DOI: 10.1097/FPC.0b013e32835aa888     Document Type: Article

References (31)

1. Giaever G, Chu AM, Ni L, Connelly C, Riles L, Veronneau S, et al. Functional profiling of the Saccharomyces cerevisiae genome. Nature 2002; 418:387-391. (Pubitemid 34826834)
2. Giaever G, Flaherty P, Kumm J, Proctor M, Nislow C, Jaramillo DF, et al. Chemogenomic profiling: identifying the functional interactions of small molecules in yeast. Proc Natl Acad Sci USA 2004; 101:793-798. (Pubitemid 38121037)
3. Lum P, Armour C, Stepaniants S, Cavet G, Wolf M, Butler J, et al. Discovering modes of action for therapeutic compounds using a genome-wide screen of yeast heterozygotes. Cell 2004; 116:121-137. (Pubitemid 38156189)
4. Hoon S, Smith AM, Wallace IM, Suresh S, Miranda M, Fung E, et al. An integrated platform of genomic assays reveals small-molecule bioactivities. Nat Chem Biol 2008; 4:498-506.
5. Parsons AB, Lopez A, Givoni IE, Williams DE, Gray CA, Porter J, et al. Exploring the mode-of-action of bioactive compounds by chemical-genetic profiling in yeast. Cell 2006; 126:611-625. (Pubitemid 44163601)
6. Crutchfield CA, Lu W, Melamud E, Rabinowitz JD. Mass spectrometry-based metabolomics of yeast. Methods Enzymol 2010; 470:393-426.
7. Cooper SJ, Finney GL, Brown SL, Nelson SK, Hesselberth J, MacCoss MJ, et al. High-throughput profiling of amino acids in strains of the Saccharomyces cerevisiae deletion collection. Genome Res 2010; 20:1288-1296.
8. Want EJ, Nordstrom A, Morita H, Siuzdak G. From exogenous to endogenous: the inevitable imprint of mass spectrometry in metabolomics. J Proteome Res 2007; 6:459-468. (Pubitemid 46340150)
9. Pasikanti KK, Ho PC, Chan ECY. Gas chromatography/mass spectrometry in metabolomic profiling of biological fluids. J Chromatogr B 2008; 871:202-211.
10. Guo K, Li L. Differential 12C-/13C-isotope dansylation labeling and fast liquid chromatography/mass spectrometry for absolute and relative quantification of the metabolome. Anal Chem 2009; 81:3919-3932.
11. Fiehn O, Kopka J, Trethewey RN, Willmitzer L. Identification of uncommon plant metabolites based on calculation of elemental compositions using gas chromatography and quadrupole mass spectrometry. Anal Chem 2000; 72:3573-3580. (Pubitemid 30614934)
12. Ghannoum MA, Rice LB. Antifungal agents: mode of action, mechanisms of resistance, and correlation of these mechanisms with bacterial resistance. Clin Microbiol Rev 1999; 12:501-517. (Pubitemid 29484744)
13. Pierce SE, Davis RW, Nislow C, Giaever G. Chemogenomic approaches to elucidation of gene function and genetic pathways. Methods Mol Biol 2009; 548:115-143.
14. Folch J, Lees M, Sloane Stanley GH. A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 1957; 226:497-509.
15. Kind T, Wohlgemuth G, Lee do Y, Lu Y, Palazoglu M, Shahbaz S, Fiehn O. FiehnLib: mass spectral and retention index libraries for metabolomics based on quadrupole and time-of-flight gas chromatography/mass spectrometry. Anal Chem 2009; 81:10038-10048.
16. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Series B 1995; 57:289-300.
17. Hastie T, Tibshirani R, Friedman J. The elements of statistical learning. New York: Springer; 2001.
18. Romero P, Wagg J, Green ML, Kaiser D, Krummenacker M, Karp PD. Computational prediction of human metabolic pathways from the complete human genome. Genome Biol 2005; 6:R2.
19. Lepesheva GI, Waterman MR. Sterol 14alpha-demethylase cytochrome P450 (CYP51), a P450 in all biological kingdoms. Biochim Biophys Acta 2007; 1770:467-477. (Pubitemid 46136743)
20. Craven RJ, Mallory JC, Hand RA. Regulation of iron homeostasis mediated by the heme-binding protein Dap1 (damage resistance protein 1) via the P450 protein Erg11/Cyp51. J Biol Chem 2007; 282:36543-36551.
21. Kubo I, Muroi H, Himejima M. Antibacterial activity of totarol and its potentiation. J Nat Prod 1992; 55:1436-1440.
22. Gachotte D, Barbuch R, Gaylor J, Nickel E, Bard M. Characterization of the Saccharomyces cerevisiae ERG26 gene encoding the C-3 sterol dehydrogenase (C-4 decarboxylase) involved in sterol biosynthesis. Proc Natl Acad Sci USA 1998; 95:13794-13799. (Pubitemid 28523052)
23. Kim H, Sablin SO, Ramsay RR. Inhibition of monoamine oxidase A by beta-carboline derivatives. Arch Biochem Biophys 1997; 337:137-142. (Pubitemid 27198065)
24. Li Y, Sattler R, Yang EJ, Nunes A, Ayukawa Y, Akhtar S, et al. Harmine, a natural beta-carboline alkaloid, upregulates astroglial glutamate transporter expression. Neuropharmacology 2010; 60:1168-1175.
25. Jahaniani F, Ebrahimi SA, Rahbar-Roshandel N, Mahmoudian M. Xanthomicrol is the main cytotoxic component of Dracocephalum kotschyii and a potential anti-cancer agent. Phytochemistry 2005; 66:1581-1592. (Pubitemid 40950551)
26. Rommelspacher H. The beta-carbolines (harmanes)-a new class of endogenous compounds: their relevance for the pathogenesis and treatment of psychiatric and neurological diseases. Pharmacopsychiatria 1981; 14:117-125. (Pubitemid 11006309)
27. Waitzinger J, Lenders H, Pabst G, Reh C, Ulbrich E. Three explorative studies on the efficacy of the antihistamine mebhydroline (Omeril). Int J Clin Pharmacol Ther 1995; 33:373-383.
28. Abadjieva A, Pauwels K, Hilven P, Crabeel M. A new yeast metabolon involving at least the two first enzymes of arginine biosynthesis: acetylglutamate synthase activity requires complex formation with acetylglutamate kinase. J Biol Chem 2001; 276:42869-42880.
29. Caspi R, Altman T, Dale JM, Dreher K, Fulcher CA, Gilham F, et al. The MetaCyc database of metabolic pathways and enzymes and the BioCyc collection of pathway/genome databases. Nucleic Acids Res 2010; 38 (Database issue):D473-D479.
30. Smith DA, Obach RS. Metabolites in safety testing (MIST): considerations of mechanisms of toxicity with dose, abundance, and duration of treatment. Chem Res Toxicol 2009; 22:267-279.
31. Guengerich FP, MacDonald JS. Applying mechanisms of chemical toxicity to predict drug safety. Chem Res Toxicol 2007; 20:344-369. (Pubitemid 46548682)